KIMBERLY LIPSCOMB: Open Payments
NPI 1699472571 · PARKERSBURG, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$952 in 70 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $1,416 · 2025 $952
Food & beverage: $952
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $327 |
| Novo Nordisk Inc | 11 | $159 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $148 |
| Amgen Inc. | 7 | $113 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Exact Sciences Corporation | 2 | $50 |
| Corcept Therapeutics | 3 | $47 |
| PFIZER INC. | 2 | $34 |
| Lilly USA, LLC | 1 | $20 |
Products named: VRAYLAR, CAPLYTA, Ozempic, QULIPTA, OTEZLA, UBRELVY, AIRSUPRA, Cologuard Collection Kit.
Industry payments across WV — which companies pay providers there.
